Shooter Ravi Kumar, boxer Sumit Sangwan fall short dope exams – Moments of India

PUNE/NEW DELHI: With just seven months to go for the

Tokyo Olympics

, two Indian sportspersons of note, shooter

Ravi Kumar

and boxer

Sumit Sangwan

, have analyzed favourable for banned substances.

It has come as a shock since just one not often hears of scenarios of dope violations in capturing and boxing, far more so if the involved athletes are global medal winners.


Ravi Kumar, 29, has represented India at all big international fulfills and won specific bronze medals at Guadalajara World Cup and

Commonwealth Games

last 12 months. According to NADA sources, Ravi was tested for the duration of the Kumar Surendra Singh Memorial satisfy in Delhi in June this yr. His sample discovered traces of


, a treatment of the beta blocker class.

Olympian Sumit Sangwan (91kg), a Tokyo hopeful, has returned beneficial for acetazolamide, a diuretic and a masking agent banned by WADA. Sangwan, 26, gained the silver medal in 2017 Asian championship and manufactured the World championship quarterfinals in 2016. His scenario has arrive just a 7 days just after major lady boxer, Neeraj (57kg), analyzed positive for ligandrol.

NADA’s anti-doping disciplinary panel heard Ravi’s defence on November 28 and has held its purchase reserved. Sources mentioned Ravi might encounter suspension for up to two a long time. Propranolol is a medication taken to take care of blood pressure, primarily just after a heart assault. It is also utilised to avoid migraine headaches. The shooter reported it was a scenario of carelessness on his part.

“I was in a predicament where by I could not feel about anything at all. I came back from the Munich Planet Cup and had a migraine attack. My sister has migraine but it was the first time I experienced these kinds of critical headache and I panicked. My mom and dad took me to a medical doctor at household and I also informed him that I am a shooter. I took the medication only following he certain me,” Ravi advised TOI.

Sangwan, a reigning nationwide champion in 91kg, was served with a recognize of adverse analytical finding (AAF) by NADA on Monday night. It is really not very clear irrespective of whether the boxer has opted for the ‘B’ sample testing or has waived off his suitable for it and rather preferred to appeal to NADA’s anti-doping disciplinary panel (ADDP).

Acetazolamide is stated as a diuretic and masking agent underneath S5 of WADA’s 2019 prohibited listing which is a specified substance. A specified compound will not simply call for an automatic suspension, but the athletes have typically been advised to choose for voluntary suspension to prevent lengthy ban interval. In Sangwan’s case, it could not be ascertained whether or not he has himself opted for the suspension or has been provisionally suspended by the NADA.

Sangwan, who represented India at the 2012 London Olympics and was adjudged the greatest boxer (81kg) at the 2015-16 elite men’s nationals, was examined in-competitors on Oct 10 during the senior nationwide championships in Baddi, Himachal Pradesh.

It is really been learnt that Sangwan was nursing an eye injuries and had taken medicines on the tips of a personal physician. Just one of the medications contained acetazolamide, which is applied to deal with significant strain within the eye thanks to sure styles of glaucoma. Even so, as demanded in a specified substance, he unsuccessful to submit the Therapeutic Use Exemption (TUE) certificate with his dope handle kind, which led to his suspension.

His odds of appearing in the impending choice trial for the Tokyo Olympic qualifiers to be held in Wuhan, China in February are as great as above.